Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	113.31	52.32	24.53
Graham Fair Price	-22.70	0.03	0.04
PEG	100.00	0.08	0.00
Price/Book	7.82	4.45	4.13
Price/Cash Flow	-89.17	1.07	-9.92
Prices/Earnings	10.67	-4.94	-5.53
Price/Sales	-74.82	2.36	9.38
Price/FCF	-89.17	1.07	-9.92
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	0.49	0.93	0.92
Operating Margin	68.39	-0.10	-0.31
ROA	42.36	< 0.005	-0.02
ROE	-0.19	-0.23	-20.70
ROIC	-0.19	-0.30	-59.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	13.86	0.00	100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	0.52	100.00
EPS QOQ	0.00	0.58	100.00
FCF QOQ	0.00	4.50	100.00
Revenue QOQ	0.00	0.51	100.00
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	241.93	315.91	30.58
Days Sales Outstanding (DSO)	0.00	2.48	100.00
Inventory Turnover	0.37	0.28	-23.42
Debt/Capitalization	< 0.005	0.14	1720.88
Quick Ratio	0.68	0.60	-12.13
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	0.02	0.01	-29.64
Cash	0.16	0.21	34.70
Capex	< 0.005	< 0.005	-116.94
Free Cash Flow	< 0.005	0.06	600.35
Revenue	< 0.005	0.03	201.33
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	1.09	1.04	-4.98
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	54.77	76.31	39.32
Naive Interpretation	Member

06 - Financial Health · Bad

Rating